About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

Not Yet RecruitingNCT06101901

Revealing Engagement Dynamics Among Diabetic Kidney Disease Patients

The study intends to investigate the personal experiences of diabetic kidney disease patients who take part in a separate clinical study including a specific medication intervention. The major focus w...

Lead sponsor: Power Life Sciences Inc.•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Michael B Gill

CONTACT

(415) 900-4227 [email protected]

Sponsors

Lead Sponsor

Power Life Sciences Inc.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patients diagnosed with diabetic kidney disease
•Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed
•Subjects willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examination.

Exclusion Criteria

•Refusal of consent
•Women of childbearing potential without a negative pregnancy test; or women who are lactating.
•Any serious and/or unstable pre-existing medical disorders

Related studies

RECRUITINGPhase 2

Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease

NCT07271186 · Diabetic Kidney Disease (DKD)

RECRUITINGPhase 2

The Evaluation of the Drug R3R01 for the Excretion of Protein in the Urine in Patients With Diabetic Kidney Disease.

NCT06600412 · Diabetic Kidney Disease

Diabetic Nephropathy in People With Diabetes. Prevalence and Predictive Factors

NCT04916132 · Chronic Kidney Diseases, Albuminuria, and more

RECRUITINGPhase 2

Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes

NCT05822609 · Diabetic Kidney Disease, Type 1 Diabetes

Effects and Safety of Diabetic GUideline Algorithm Implementation Performed by Primary Care Physicians in the Community

NCT05349955 · Type 2 Diabetes, Cardiovascular Complication, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 26, 2023Terms

Trial snapshot

StatusNOT_YET_RECRUITING

Phase—

Enrollment500

Start dateNov 2024

Last updatedOct 26, 2023

Condition

Diabetic Kidney Disease

Locations shown

Power Life Sciences

San Francisco, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 26, 2023Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions